Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|February 28, 2003
Novel antibacterial agents for the treatment of serious Gram-positive infectionsDarren Abbanat, Mark Macielag, Karen BushCurrent Opinion in Microbiology|September 29, 2004
Taking inventory: antibacterial agents currently at or beyond phase 1Karen Bush, Mark Macielag, Michele Weidner-WellsBioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximesXiaodong Xu, Todd Henninger, Darren Abbanat, et al.Antimicrobial Agents and Chemotherapy|December 24, 2004
In vitro activities of novel 2-fluoro-naphthyridine-containing ketolidesDarren Abbanat, Glenda Webb, Barbara Foleno, et al.Antimicrobial Agents and Chemotherapy|October 3, 2007
A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coliEllen Z Baum, Steven M Crespo-Carbone, Alexandra Klinger, et al.The Journal of Antibiotics|May 18, 2005
15-amido erythromycins: synthesis and in vitro activity of a new class of macrolide antibioticsSimon J Shaw, Darren Abbanat, Gary W Ashley, et al.Antimicrobial Agents and Chemotherapy|May 28, 2009
MurF inhibitors with antibacterial activity: effect on muropeptide levelsEllen Z Baum, Steven M Crespo-Carbone, Barbara D Foleno, et al.ACS Medicinal Chemistry Letters|January 21, 2022
Discovery and Optimization of 7-Alkylidenyltetrahydroindazole-Based Acylsulfonamide EP3 AntagonistsBin Zhu, Xuqing Zhang, Lili Guo, et al.Nature Medicine|December 22, 2005
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseAri Robicsek, Jacob Strahilevitz, George A Jacoby, et al.Bioorganic & Medicinal Chemistry Letters|June 6, 2021
Optimization of physicochemical properties of pyridone-based EP3 receptor antagonistsXuqing Zhang, Bin Zhu, Lili Guo, et al.Pageof 2